We are live on ! Find out more
KE

KLP Enterprises Portfolio holdings

AUM $1.97M
This Fund
S&P 500
This Quarter Est. Return
-78.4%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.46M
AUM Growth
-$12.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CLDX icon
1
Celldex Therapeutics
CLDX
$2.2B
$3.46M 100%
457,667
– –
2016 Q4
6 quarters

Similar funds

KLP Enterprises's Q2 2018 Portfolio in Review

As of Q2 2018, KLP Enterprises held 1 position worth $3.46M, down 78% from $16M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 0%. KLP Enterprises opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KLP Enterprises's ten largest holdings make up 100% of its $3.46M portfolio in Q2 2018.
  • KLP Enterprises opened 0 new positions and closed 0 in Q2 2018.
  • KLP Enterprises's portfolio value fell 78% quarter-over-quarter to $3.46M.

Based on KLP Enterprises's 13F filing for Q2 2018, filed 10 Aug 2018.